News from REMEDY

Don't miss this year's hashtag # MUSS, the National Musculoskeletal Health Research Conference!

Today, all patients with rheumatoid arthritis (arthritis) receive the same dose of biological drugs. The researchers are now investigating whether an individually adapted dose means that more people will get a better effect from the medicines.

A recent study by researchers at Diakonhjemmet Hospital shows that almost half of the physiotherapists in the primary healthcare service who answered the survey use digital health technology (DHT) in the treatment of musculoskeletal disorders.

Do you want to travel abroad to participate in a relevant research group? Read more here: 

Rheumatic diseases increase the risk of additional diseases, especially cardiovascular diseases. Therefore, rehabilitation is individually adapted. Physiotherapists at Diakonhjemmet hospital use advanced tools, such as the Cardiopulmonary Exercise Test (CPET) to develop optimal rehabilitation plans.

The Norwegian professional environment in rheumatology is at the forefront of research and treatment in the world. In the new textbook, Rheumatology, 77 experts from 17 different disciplines share their insights. The book is a comprehensive resource on inflammatory rheumatic diseases, developed for medical students, but also valuable for other healthcare professionals.

The study that shows this is part of the REMEDY project, ReMonit. It is a research study with patients with the chronic disease axial spondyloarthritis. The disease leads to inflammation that causes pain and stiffness in the back. 

Are you interested in how rheumatic diseases are often the result of other health challenges? Then this free seminar, with the theme of comorbidity, is for you! Now you can watch the recordings from parts of the Dialogue Seminar. 

Doctor Marthe Kirkesæther Brun talks in this webinar about research findings that can give many patients better treatment. The webinar is entitled Personalized treatment of inflammatory diseases - monitoring drug levels and antibodies. 

Premiere 31 August at 0830